COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2231: Articles 22301-22310  | Next

Covid-19 Belgium: Extended SEIR-QD model with nursery homes and long-term scenarios-based forecasts from school opening
Franco, N.
10.1101/2020.09.07.20190108 — Posted: 2020-09-09
Passive, open access data measures movement and predicts COVID-19 cases
Faust, C. L., Lambert, B., Kochenour, C., Robinson, A. C., Bharti, N.
10.1101/2020.09.09.20190389 — Posted: 2020-09-09
Tracking Smell Loss to Identify Healthcare Workers with SARS-CoV-2 Infection
Weiss, J. J., Attuquayefio, T. N., White, E. B., Li, F., Herz, R. S., White, T. L., Campbell, M., Geng, B., Datta, R., Wyllie, A. L., Grubaugh, N. D., Casanovas-Massana, A., Muenker, M. C., Handoko, R., Iwasaki, A., The Yale IMPACT Research Team, , Martinello, R. A., Ko, A. I., Small, D. M., Farhadian, S. F.
10.1101/2020.09.07.20188813 — Posted: 2020-09-09
Understanding SARSCOV-2 propagation, impacting factors to derive possible scenarios and simulations
Mehl-Madrona, L. E., Bricaire, F., Cuyugan, A., Barac, J., Parvaiz, A., Jamil, A. B., Iqbal, S., Sellier, M. K.
10.1101/2020.09.07.20190066 — Posted: 2020-09-09 Discussion: Onsite
Insufficient hyperfibrinolysis in COVID-19: a systematic review of thrombolysis based on meta-analysis and meta-regression
Ji, H.-L. J., Su, Z., Zhao, R., Komissarov, A. A., Yi, G., Liu, S.-L., Idell, S., Matthay, M. A.
10.1101/2020.09.07.20190165 — Posted: 2020-09-09
EARLY VIRAL CLEARANCE AMONG COVID-19 PATIENTS WHEN GARGLING WITH POVIDONE-IODINE AND ESSENTIAL OILS: A PILOT CLINICAL TRIAL
MOHAMED, N. A., BAHAROM, N., WAN SULAIMAN, W. S., ZAINOL RASHID, Z., WONG, K. K., ALI, U. K., OTHMAN, S. N., ABD SAMAD, M. N., KORI, N., PERIYASAMY, P., ZAKARIA, N. A., SUGUMAR, A. N. K., MOHAMMAD KAZMIN, N. E., CHEONG, X. K., SANIMAN, S. M., ISAHAK, I.
10.1101/2020.09.07.20180448 — Posted: 2020-09-09 Discussion: Onsite
Airborne contamination of COVID-19 in hospitals: a scoping review of the current evidence.
BIRGAND, G., PEIFFER-SMADJA, N., Fournier, S., Kerneis, S., Lescure, F. X., Lucet, J.-C.
10.1101/2020.09.09.20191213 — Posted: 2020-09-09 Discussion: Offsite
Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2
Perez-Garcia, F., Perez-Tanoira, R., Iglesias, M. E., Romanyk, J., Arroyo, T., Gomez-Herruz, P., Gonzalez, R., Cuadros-Gonzalez, J.
10.1101/2020.09.08.20190488 — Posted: 2020-09-09 Discussion: Offsite
The role of NIH funding in vaccine readiness; foundational research and NIH funding underlying candidate SARS-CoV-2 vaccines
Kiszewski, A. E., Galkina Cleary, E. I., Jackson, M. J., Ledley, F. D.
10.1101/2020.09.08.20187559 — Posted: 2020-09-09 Discussion: Onsite
Self-learning on COVID-19 among medical students and their preparedness to participate in government's COVID-19 response in Bhutan: a cross-sectional study
Dorji, T., Tamang, S. T., Tilak, T.
10.1101/2020.09.07.20189936 — Posted: 2020-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).